found that HK2 silencing can synergistically enhance the sensitivity of HCC to sorafenib.[31] HK2 attenuation enhances the sensitivity of HCC to drugs such as metformin by inhibiting glycolytic flux and inducing OXPHOS. This evidence concerns the gene HK2 and hepatocellular carcinoma.